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BACKGROUND SYNTHESIS – FRAMEWORK 1 SCREENING PROCESS
FUTURE WORK
Goal: To successfully synthesize and characterize a library of ortho/para-quinone methide precursors
(QMPs) derived from commercially available materials and to evaluate the nucleophilic reactivity of
these precursors with various sulfur, oxygen and nitrogen-based nucleophiles.
The treatment for exposure to chemical warfare agents, such as organophosphorus (OP) nerve agents that inhibit
acetylcholinesterase (AChE) causing severe nerve damage, and in some cases death, is an important area of research.
Each AChE hydrolyzes 25,000 molecules per second.  
Active site residues: (Ser 203, His 447, Glu 334)
Inhibition
Bradycardia
Hypotension
Hypersecretion
GI tract hypermotility
Decrease intraocular pressure
Bronchoconstriction
Prolonged muscular contraction
SYNTHESIS – FRAMEWORK 2
Organophosphorus (OP) Nerve Agents
Organophosphorus Compounds
Mode of Action 
Procedure: The reagents are combined in methanol and heated. During heating, the reaction begins with 
nucleophilic addition of the amine to the carbonyl of the aldehyde. The resulting intermediate is then 
reduced by the sodium cyanoborohydride to form the amine product. Protonation is then performed 
following extraction. The pronated QMP is finally isolated from any impurities using trituration. 
Goal: To screen our library of protonated quinone methide precursors prior to testing in the AChE
enzyme active site by evaluating the nucleophilic reactivity of each with various nucleophiles.
Procedure: A small amount of protonated QMP is combined in solution with a nucleophile and heated. 
After the heating period, the reaction is diluted and analyzed via GC/MS. Though the protonated starting 
material is not visible using this instrument, it allows us to see the neutral products and quantify the 
conversion using an internal standard. Goal: To expand our library of QMP’s by synthesizing a number of pyridine based compounds. The
computational methods that have been used to guide synthetic efforts have shown promise in these
compounds.
Procedure: The reagents are combined in water and heated. During heating, the amine first participates in 
a Mannich reaction with the formaldehyde to form an electrophile.  The pyridol ring then attacks the newly 
formed electrophile through an EAS pathway. The resulting QMP is extracted and protonated to give the 
QMP-HCl.
UV STUDIES – ELLMAN’S ASSAY 
Goal: To determine if a QMP of interest is a competitive inhibitor via UV-vis monitoring of Ellman’s assay.
Procedure: Ellman’s assay uses the thiol ester acetylthiocholine (ATC) in place of acetylcholine. The ATC is 
hydrolyzed by the enzyme AChE to produce thiocholine and acetate. The thiocholine then reduces the 
dithionitrobenzoate (DTNB) to ultimately give  thionitrobenzoate (TNB) which absorbs at 405 nm. When 
the QMP of interest in added into the assay, the change in absorbance can be measured via UV-vis in order 
to determine if the QMP is in fact a competitive inhibitor.
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Potential oximes that reverse OP exposure if the enzyme is in the inhibited form.
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A quinone methide could potentially be used to realkylate the aged enzyme.
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